Vascular disease is the leading cause of morbidity and mortality in the United States. There is a public health need for increased transfer of knowledge between the various disciplines that constitute this research field, and accelerated application of the basic information to clinical practice. The Stanford program addresses with a multidisciplinary program and faculty performing scientific and clinical work related directly to Vascular Medicine including cardiovascular and pulmonary medicine, endocrinology, hematology, nephrology, immunology, epidemiology and clinical trials design, cell and molecular biology, developmental and stem cell biology, tissue and mechanical engineering, physics and computational modeling, genetics/genomics,proteomics, physiology and molecular pharmacology. This proposal is designed to address the educational and clinical needs in the emerging specialty of Vascular Medicine. The program will produce clinician investigators with a deep fund of knowledge regarding vascular medicine, and a high level of proficiency in clinical research. This new breed of investigators will apply cutting edge technology to clinically relevant questions in vascular medicine, and they will be able to train the next generation of vascular internists.
Our Specific aims are to: 1) Develop, institute and annually evaluate a one year core clinical training program that confers competency in the management of arterial, venous and lymphatic diseases and associated disorders;2) Formulate, initiate and annually update a didactic training program in clinical research emphasizing clinical trial design, biostatistics and bioinformatics, genomics and proteomics, regulatory affairs, and responsible conduct of research;3) Provide a clinical research experience guided by an experienced Mentor, facilitated by a cohort of collaborative Co-mentors, and focused on a clinical research project. Other elements include exposure to trial design, interaction with and direct participation on the Institutional Review Board, database management and analysis, manuscript preparation, and grant writing. Lay description: Diseases of the arteries and veins cause most of the hospitalizations and deaths in the United States. Stanford University proposes a comprehensive educational program that will train a new breed of doctors that can recognize and treat these diseases, develop new therapies, and train young doctors in the care of people with vessel disease. (End of Abstract).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12HL087746-05
Application #
8324232
Study Section
Special Emphasis Panel (ZHL1-CSR-A (F1))
Program Officer
Reid, Diane M
Project Start
2007-04-01
Project End
2014-03-31
Budget Start
2012-04-01
Budget End
2014-03-31
Support Year
5
Fiscal Year
2012
Total Cost
$521,553
Indirect Cost
$47,088
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Corey, Daniel M; Rosental, Benyamin; Kowarsky, Mark et al. (2016) Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners. Proc Natl Acad Sci U S A 113:6520-5
Chang, Peter; Nead, Kevin T; Olin, Jeffrey W et al. (2015) Effect of physical activity assessment on prognostication for peripheral artery disease and mortality. Mayo Clin Proc 90:339-45
Sukhovershin, Roman A; Ghebremariam, Yohannes T; Cooke, John P (2015) Lansoprazole worsens asthma control in poor metabolizers: is nitric oxide involved? Ann Am Thorac Soc 12:1109-10
Dunn, Louise L; Simpson, Philippa J L; Prosser, Hamish C et al. (2014) A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis. Diabetes 63:675-87
Ghebremariam, Yohannes T; Erlanson, Daniel A; Cooke, John P (2014) A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide. J Pharmacol Exp Ther 348:69-76
Ghebremariam, Yohannes T; Huang, Ngan F; Kambhampati, Swetha et al. (2014) Characterization of a fluorescent probe for imaging nitric oxide. J Vasc Res 51:68-79
Ghebremariam, Yohannes T; Lee, Jerry C; LePendu, Paea et al. (2014) Response to letters regarding article, ""unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine"". Circulation 129:e428
Priest, James R; Nead, Kevin T; Wehner, Mackenzie R et al. (2014) Self-reported history of childhood smoking is associated with an increased risk for peripheral arterial disease independent of lifetime smoking burden. PLoS One 9:e88972
Botham, Crystal M; Bennett, William L; Cooke, John P (2013) Clinical trials of adult stem cell therapy for peripheral artery disease. Methodist Debakey Cardiovasc J 9:201-5
Voskoboynik, Ayelet; Neff, Norma F; Sahoo, Debashis et al. (2013) The genome sequence of the colonial chordate, Botryllus schlosseri. Elife 2:e00569

Showing the most recent 10 out of 57 publications